Table 4.
The subgroup analysis of included published studies.
| Analysis | No. of studies | Sample size | OR | 95% CI | P |
|---|---|---|---|---|---|
| Brazil | |||||
| Adverse events | 2 | 460 | 0.92 | 0.82 to 1.03 | 0.15 |
| Serious adverse event | 1 | 179 | 0.97 | 0.25 to 3.75 | 0.96 |
| China | |||||
| Adverse events | 2 | 368 | 0.79 | 0.61 to 1.02 | 0.07 |
| Serious adverse event | 2 | 368 | 0.33 | 0.04 to 2.69 | 0.3 |
| Russia | |||||
| Adverse events | 1 | 314 | 0.97 | 0.64 to 1.47 | 0.89 |
| Serious adverse event | 1 | 314 | 0.33 | 0.01 to 8.12 | 0.5 |